Skip to main content Back to Top
Advertisement

5/26/2016

Secretin Injection

Products Affected - Description

    • ChiRhoStim lyophilized powder for solution for injection, ChiRhoClin, 16 mcg, vial, single count NDC 67066-0005-01

Reason for the Shortage

    • ChiRhoClin is qualifying a manufacturing site.
    • ChiRhoClin has been working with FDA to release ChiRhoStim lot #0636149. This lot was produced at a new manufacturing site that has not been approved by FDA. Please see the Dear Health Care Provider letter for additional information (http://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/UCM399083.pdf). ChiRhoClin anticipates the release of a new ChiRhoStim lot in 2015.
    • Additional information is available at: http://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/UCM399083.pdf.

Estimated Resupply Dates

    • ChiRhoClin has ChiRhoStim available. Order product through your wholesaler or by direct order.

Safety

    • ChiRhoStim from batch #0636149 should be filtered using a Millex-GV Syringe Microbial Filter Unit prior to administration. These filters are included with each vial of ChiRhoStim.

Updated

Updated May 26, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Created May 9, 2012 by Erin R. Fox, PharmD, Director, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins